{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["COVID-19", "docking", "drug design", "molecular dynamics", "traditional medicine"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "34026798", "DateRevised": {"Year": "2021", "Month": "05", "Day": "26"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "05", "Day": "07"}], "Language": ["eng"], "ELocationID": ["672629", "10.3389/fmed.2021.672629"], "Journal": {"ISSN": "2296-858X", "JournalIssue": {"Volume": "8", "PubDate": {"Year": "2021"}}, "Title": "Frontiers in medicine", "ISOAbbreviation": "Front Med (Lausanne)"}, "ArticleTitle": "Phytochemical Moieties From Indian Traditional Medicine for Targeting Dual Hotspots on SARS-CoV-2 Spike Protein: An Integrative <i>in-silico</i> Approach.", "Pagination": {"StartPage": "672629", "MedlinePgn": "672629"}, "Abstract": {"AbstractText": ["SARS-CoV-2 infection across the world has led to immense turbulence in the treatment modality, thus demanding a swift drug discovery process. Spike protein of SARS-CoV-2 binds to ACE2 receptor of human to initiate host invasion. Plethora of studies demonstrate the inhibition of Spike-ACE2 interactions to impair infection. The ancient Indian traditional medicine has been of great interest of Virologists worldwide to decipher potential antivirals. Hence, in this study, phytochemicals (1,952 compounds) from eight potential medicinal plants used in Indian traditional medicine were meticulously collated, based on their usage in respiratory disorders, along with immunomodulatory and anti-viral potential from contemporary literature. Further, these compounds were virtually screened against Receptor Binding Domain (RBD) of Spike protein. The potential compounds from each plant were prioritized based on the binding affinity, key hotspot interactions at ACE2 binding region and glycosylation sites. Finally, the potential hits in complex with spike protein were subjected to Molecular Dynamics simulation (450 ns), to infer the stability of complex formation. Among the compounds screened, Tellimagrandin-II (binding energy of -8.2 kcal/mol and binding free energy of -32.08 kcal/mol) from <i>Syzygium aromaticum</i> L. and O-Demethyl-demethoxy-curcumin (binding energy of -8.0 kcal/mol and binding free energy of -12.48 kcal/mol) from <i>Curcuma longa</i> L. were found to be highly potential due to their higher binding affinity and significant binding free energy (MM-PBSA), along with favorable ADMET properties and stable intermolecular interactions with hotspots (including the ASN343 glycosylation site). The proposed hits are highly promising, as these are resultant of stringent <i>in silico</i> checkpoints, traditionally used, and are documented through contemporary literature. Hence, could serve as promising leads for subsequent experimental validations."], "CopyrightInformation": "Copyright \u00a9 2021 Umashankar, Deshpande, Hegde, Singh and Chattopadhyay."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "ICMR-National Institute of Traditional Medicine, Indian Council of Medical Research, Department of Health Research (Government of India), Belagavi, India."}], "LastName": "Umashankar", "ForeName": "V", "Initials": "V"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "ICMR-National Institute of Traditional Medicine, Indian Council of Medical Research, Department of Health Research (Government of India), Belagavi, India."}], "LastName": "Deshpande", "ForeName": "Sanjay H", "Initials": "SH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "ICMR-National Institute of Traditional Medicine, Indian Council of Medical Research, Department of Health Research (Government of India), Belagavi, India."}], "LastName": "Hegde", "ForeName": "Harsha V", "Initials": "HV"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "ICMR-National Institute of Traditional Medicine, Indian Council of Medical Research, Department of Health Research (Government of India), Belagavi, India."}], "LastName": "Singh", "ForeName": "Ishwar", "Initials": "I"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "ICMR-National Institute of Traditional Medicine, Indian Council of Medical Research, Department of Health Research (Government of India), Belagavi, India."}], "LastName": "Chattopadhyay", "ForeName": "Debprasad", "Initials": "D"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Front Med (Lausanne)", "NlmUniqueID": "101648047", "ISSNLinking": "2296-858X"}, "CoiStatement": "The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Wang W, Xu Y, Gao R, Lu R, Han K, Wu G, et al. . Detection of SARS-CoV-2 in different types of clinical specimens. JAMA. (2020) 323:1843\u20131844. 10.1001/jama.2020.3786", "ArticleIdList": ["10.1001/jama.2020.3786", "PMC7066521", "32159775"]}, {"Citation": "Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. . A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. (2020) 382:727\u201333. 10.1056/NEJMoa2001017", "ArticleIdList": ["10.1056/NEJMoa2001017", "PMC7092803", "31978945"]}, {"Citation": "Chan JF-W, Kok K-H, Zhu Z, Chu H, To KK-W, Yuan S, et al. . Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg Microb Infect. (2020) 9:221\u201336. 10.1080/22221751.2020.1719902", "ArticleIdList": ["10.1080/22221751.2020.1719902", "PMC7067204", "31987001"]}, {"Citation": "WHO . WHO Media Briefing on COVID-19- 11 March 2020. (2020). Available online at: https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19\u201311-march-2020 (accessed September 14, 2020)."}, {"Citation": "Worldometer (2021). Available online at: https://www.worldometers.info/coronavirus/ (accessed April 02, 2021)."}, {"Citation": "Huang Y, Yang C, Xu X, Xu W, Liu S. Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19. Acta Pharmacologica Sinica. (2020) 41:1141\u20139. 10.1038/s41401-020-0485-4", "ArticleIdList": ["10.1038/s41401-020-0485-4", "PMC7396720", "32747721"]}, {"Citation": "Wrapp D, Wang N, Corbett KS, Goldsmith JA, Hsieh C-L, Abiona O, et al. . Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science. (2020) 367:1260\u20133. 10.1126/science.abb2507", "ArticleIdList": ["10.1126/science.abb2507", "PMC7164637", "32075877"]}, {"Citation": "Hoffmann M, M\u00fcller MA, Drexler JF, Glende J, Erdt M, G\u00fctzkow T, et al. . Differential sensitivity of bat cells to infection by enveloped RNA viruses: coronaviruses, paramyxoviruses, filoviruses, and influenza viruses. PLoS ONE. (2013) 8:e72942. 10.1371/journal.pone.0072942", "ArticleIdList": ["10.1371/journal.pone.0072942", "PMC3758312", "24023659"]}, {"Citation": "Hasan A, Paray BA, Hussain A, Qadir FA, Attar F, Aziz FM, et al. . A review on the cleavage priming of the spike protein on coronavirus by angiotensin-converting enzyme-2 and furin. J Biomol Struct Dyn. (2020). 1\u20139. 10.1080/07391102.2020.1754293", "ArticleIdList": ["10.1080/07391102.2020.1754293", "PMC7189411", "32274964"]}, {"Citation": "Walls AC, Park Y-J, Tortorici MA, Wall A, McGuire AT, Veesler D. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell. (2020) 181:281\u201392.e6. 10.1016/j.cell.2020.02.058", "ArticleIdList": ["10.1016/j.cell.2020.02.058", "PMC7102599", "32155444"]}, {"Citation": "Wu Y, Wang F, Shen C, Peng W, Li D, Zhao C, et al. . A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2. Science. (2020) 368:1274\u20138. 10.1126/science.abc2241", "ArticleIdList": ["10.1126/science.abc2241", "PMC7223722", "32404477"]}, {"Citation": "Ge X-Y, Li J-L, Yang X-L, Chmura AA, Zhu G, Epstein JH, et al. . Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor. Nature. (2013) 503:535\u20138. 10.1038/nature12711", "ArticleIdList": ["10.1038/nature12711", "PMC5389864", "24172901"]}, {"Citation": "Gralinski LE, Menachery VD. Return of the coronavirus: 2019-nCoV. Viruses. (2020) 12:135. 10.3390/v12020135", "ArticleIdList": ["10.3390/v12020135", "PMC7077245", "31991541"]}, {"Citation": "Singh I, Vetrivel U, Harish DR, Chattophadhyay D. Coding-complete genome sequences of NITMA1086 and NITMA1139, two SARS-CoV-2 isolates from Belagavi District, Karnataka State, India, Harboring the D614G mutation. Microbiol Resour Announc. (2021) 10:e00016-21. 10.1128/MRA.00016-21", "ArticleIdList": ["10.1128/MRA.00016-21", "PMC7883838", "33574104"]}, {"Citation": "Shajahan A, Supekar NT, Gleinich AS, Azadi P. Deducing the N- and O-glycosylation profile of the spike protein of novel coronavirus SARS-CoV-2. Glycobiology. (2020) 30:981\u20138. 10.1093/glycob/cwaa042", "ArticleIdList": ["10.1093/glycob/cwaa042", "PMC7239183", "32363391"]}, {"Citation": "Watanabe Y, Allen JD, Wrapp D, McLellan JS, Crispin M. Site-specific glycan analysis of the SARS-CoV-2 spike. Science. (2020) 369:eabb9983. 10.1126/science.abb9983", "ArticleIdList": ["10.1126/science.abb9983", "PMC7199903", "32366695"]}, {"Citation": "Shang J, Ye G, Shi K, Wan Y, Luo C, Aihara H, et al. . Structural basis of receptor recognition by SARS-CoV-2. Nature. (2020) 581:221\u20134. 10.1038/s41586-020-2179-y", "ArticleIdList": ["10.1038/s41586-020-2179-y", "PMC7328981", "32225175"]}, {"Citation": "Enayatkhani M, Hasaniazad M, Faezi S, Gouklani H, Davoodian P, Ahmadi N, et al. . Reverse vaccinology approach to design a novel multi-epitope vaccine candidate against COVID-19: an in silico study. J Biomol Struct Dyn. (2020). 10.1080/07391102.2020.1756411. [Epub ahead of print].", "ArticleIdList": ["10.1080/07391102.2020.1756411", "PMC7196925", "32295479"]}, {"Citation": "Muralidharan N, Sakthivel R, Velmurugan D, Gromiha MM. Computational studies of drug repurposing and synergism of lopinavir, oseltamivir and ritonavir binding with SARS-CoV-2 protease against COVID-19. J Biomol Struct Dyn. (2020). 10.1080/07391102.2020.1752802. [Epub ahead of print].", "ArticleIdList": ["10.1080/07391102.2020.1752802", "32248766"]}, {"Citation": "Wahedi HM, Ahmad S, Abbasi SW. Stilbene-based natural compounds as promising drug candidates against COVID-19. J Biomol Struct Dyn. (2020). 10.1080/07391102.2020.1762743. [Epub ahead of print].", "ArticleIdList": ["10.1080/07391102.2020.1762743", "32345140"]}, {"Citation": "Parvathaneni V, Gupta V. Utilizing drug repurposing against COVID-19\u2013 efficacy, limitations, and challenges. Life Sci. (2020) 259:118275. 10.1016/j.lfs.2020.118275", "ArticleIdList": ["10.1016/j.lfs.2020.118275", "PMC7430345", "32818545"]}, {"Citation": "Enmozhi SK, Raja K, Sebastine I, Joseph J. Andrographolide as a potential inhibitor of SARS-CoV-2 main protease: an in silico approach. J Biomol Struct Dyn. (2020). 10.1080/07391102.2020.1760136. [Epub ahead of print].", "ArticleIdList": ["10.1080/07391102.2020.1760136", "PMC7212536", "32329419"]}, {"Citation": "Elmezayen AD, Al-Obaidi A, Sahin AT, Yelek\u00e7i K. Drug repurposing for coronavirus (COVID-19): in silico screening of known drugs against coronavirus 3CL hydrolase and protease enzymes. J Biomol Struct Dyn. (2020). 10.1080/07391102.2020.1758791. [Epub ahead of print].", "ArticleIdList": ["10.1080/07391102.2020.1758791", "PMC7189413", "32306862"]}, {"Citation": "Naik SR, Bharadwaj P, Dingelstad N, Kalyaanamoorthy S, Mandal SC, Ganesan A, et al. . Structure-based virtual screening, molecular dynamics and binding affinity calculations of some potential phytocompounds against SARS-CoV-2. J Biomol Struct Dyn. (2021). 10.1080/07391102.2021.1891969. [Epub ahead of print].", "ArticleIdList": ["10.1080/07391102.2021.1891969", "33682632"]}, {"Citation": "Ansar S, Vetrivel U. Structure-based design of small molecule and peptide inhibitors for selective targeting of ROCK1: an integrative computational approach. J Biomol Struct Dyn. (2021). 10.1080/07391102.2021.1898470. [Epub ahead of print].", "ArticleIdList": ["10.1080/07391102.2021.1898470", "33715594"]}, {"Citation": "Nagarajan H, Vetrivel U. Membrane dynamics simulation and virtual screening reveals potential dual natural inhibitors of endothelin receptors for targeting glaucomatous condition. Life Sci. (2021) 269:119082. 10.1016/j.lfs.2021.119082", "ArticleIdList": ["10.1016/j.lfs.2021.119082", "33482184"]}, {"Citation": "Sivashanmugam M, Sulochana KN, Umashankar V. Virtual screening of natural inhibitors targeting ornithine decarboxylase with pharmacophore scaffolding of DFMO and validation by molecular dynamics simulation studies. J Biomol Struct Dyn. (2019) 37:766\u201380. 10.1080/07391102.2018.1439772", "ArticleIdList": ["10.1080/07391102.2018.1439772", "29436980"]}, {"Citation": "Yi Y, Hsieh I-Y, Huang X, Li J, Zhao W. Glioblastoma stem-like cells: characteristics, microenvironment, and therapy. Front Pharmacol. (2016) 7:477. 10.3389/fphar.2016.00477", "ArticleIdList": ["10.3389/fphar.2016.00477", "PMC5141588", "28003805"]}, {"Citation": "Yi F, Li L, Xu L, Meng H, Dong Y, Liu H, et al. . In silico approach in reveal traditional medicine plants pharmacological material basis. Chin Med. (2018) 13:33. 10.1186/s13020-018-0190-0", "ArticleIdList": ["10.1186/s13020-018-0190-0", "PMC6006786", "29946351"]}, {"Citation": "Chattopadhyay D, Khan MTH. Ethnomedicines and ethnomedicinal phytophores against herpesviruses. Biotechnol Annu Rev. (2008) 14:297\u2013348. 10.1016/S1387-2656(08)00012-4", "ArticleIdList": ["10.1016/S1387-2656(08)00012-4", "18606369"]}, {"Citation": "Debprasad C. Ethnomedicine: A Source of Complementary Therapeutics. Trivandrum: Research Signpost; (2010)."}, {"Citation": "Chattopadhyay D, Naik T. Antivirals of ethnomedicinal origin: structure-activity relationship and scope. Mini Revi Med Chem. (2007) 7:275\u2013301. 10.2174/138955707780059844", "ArticleIdList": ["10.2174/138955707780059844", "17346219"]}, {"Citation": "Nair A, Chattopadhyay D, Saha B. Chapter 17 - plant-derived immunomodulators. In: Ahmad Khan MS, Ahmad I, Chattopadhyay D, editors. New Look to Phytomedicine. London: Academic Press; (2019). p. 435\u201399. 10.1016/B978-0-12-814619-4.00018-5", "ArticleIdList": ["10.1016/B978-0-12-814619-4.00018-5"]}, {"Citation": "Das MA, Bhowmik P, Banerjee A, Das A, Ojha D, Chattopadhyay D. Chapter 3 - ethnomedicinal wisdom: an approach for antiviral drug development. In: Ahmad Khan MS, Ahmad I, Chattopadhyay D, editors. New Look to Phytomedicine. London: Academic Press; (2019). p. 35\u201361. 10.1016/B978-0-12-814619-4.00003-3", "ArticleIdList": ["10.1016/B978-0-12-814619-4.00003-3"]}, {"Citation": "Chattopadhyay D, Sarkar MC, Chatterjee T, Sharma Dey R, Bag P, Chakraborti S, et al. . Recent advancements for the evaluation of antiviral activities of natural products. N Biotechnol. (2009) 25:347\u201368. 10.1016/j.nbt.2009.03.007", "ArticleIdList": ["10.1016/j.nbt.2009.03.007", "PMC7185506", "19464980"]}, {"Citation": "Chattopadhyay D, Ojha D, Mondal S, Goswami D. \u201cValidation of antiviral potential of herbal ethnomedicine. In: Evidence-Based Validation of Herbal Medicine Elsevier (2015). p. 175\u2013200. 10.1016/B978-0-12-800874-4.00008-8", "ArticleIdList": ["10.1016/B978-0-12-800874-4.00008-8"]}, {"Citation": "Fernandes MJB. Screening of Brazilian plants for antiviral activity against animal herpesviruses. J Med Plants Res. (2012) 6:2261\u20135. 10.5897/JMPR10.040", "ArticleIdList": ["10.5897/JMPR10.040"]}, {"Citation": "Kuo Y-C, Lin L-C, Tsai W-J, Chou C-J, Kung S-H, Ho Y-H. Samarangenin B from limonium sinense suppresses herpes simplex virus type 1 replication in vero cells by regulation of viral macromolecular synthesis. Antimicrob Agents Chemother. (2002) 46:2854\u201364. 10.1128/AAC.46.9.2854-2864.2002", "ArticleIdList": ["10.1128/AAC.46.9.2854-2864.2002", "PMC127446", "12183238"]}, {"Citation": "Bag P, Ojha D, Mukherjee H, Halder UC, Mondal S, Biswas A, et al. . A dihydro-pyrido-indole potently inhibits HSV-1 infection by interfering the viral immediate early transcriptional events. Antiv Res. (2014) 105:126\u201334. 10.1016/j.antiviral.2014.02.007", "ArticleIdList": ["10.1016/j.antiviral.2014.02.007", "24576908"]}, {"Citation": "Bag P, Chattopadhyay D, Mukherjee H, Ojha D, Mandal N, Sarkar M, et al. . Anti-herpes virus activities of bioactive fraction and isolated pure constituent of Mallotus peltatus: an ethnomedicine from Andaman Islands. Virol J. (2012) 9:98. 10.1186/1743-422X-9-98", "ArticleIdList": ["10.1186/1743-422X-9-98", "PMC3430555", "22624581"]}, {"Citation": "Ojha D, Mukherjee H, Ghosh S, Bag P, Mondal S, Chandra NS, et al. . Evaluation of anti-infective potential of a tribal folklore Odina wodier Roxb against some selected microbes and herpes simplex virus associated with skin infection. J Appl Microbiol. (2013) 115:1317\u201328. 10.1111/jam.12330", "ArticleIdList": ["10.1111/jam.12330", "23957446"]}, {"Citation": "Cos P, Berghe D, Bruyne T, Vlietinck A. Plant substances as antiviral agents: an update (1997-2001). Curr Organ Chem. (2003) 7:1163\u201380. 10.2174/1385272033486558", "ArticleIdList": ["10.2174/1385272033486558"]}, {"Citation": "Ghosh S, Chattopadhyay D, Mandal A, Kaity S, Samanta A. Bioactivity guided isolation of antiinflammatory, analgesic, and antipyretic constituents from the leaves of Pedilanthus tithymaloides (L.). Med Chem Res. (2013) 22:4347\u201359. 10.1007/s00044-012-0449-4", "ArticleIdList": ["10.1007/s00044-012-0449-4"]}, {"Citation": "Ojha D, Das R, Sobia P, Dwivedi V, Ghosh S, Samanta A, et al. . Pedilanthus tithymaloides inhibits HSV infection by modulating NF-\u03baB signaling. PLoS ONE. (2015) 10:e0139338. 10.1371/journal.pone.0139338", "ArticleIdList": ["10.1371/journal.pone.0139338", "PMC4583282", "26405764"]}, {"Citation": "Halder A, Das S, Ojha D, Chattopadhyay D, Mukherjee A. Highly monodispersed gold nanoparticles synthesis and inhibition of herpes simplex virus infections. Mater Scie Eng C. (2018) 89:413\u201321. 10.1016/j.msec.2018.04.005", "ArticleIdList": ["10.1016/j.msec.2018.04.005", "29752114"]}, {"Citation": "Goswami D, Das Mahapatra A, Banerjee S, Kar A, Ojha D, Mukherjee PK, et al. . Boswellia serrata oleo-gum-resin and \u03b2-boswellic acid inhibits HSV-1 infection in vitro through modulation of NF-\u03baB and p38 MAP kinase signaling. Phytomedicine. (2018) 51:94\u2013103. 10.1016/j.phymed.2018.10.016", "ArticleIdList": ["10.1016/j.phymed.2018.10.016", "30466633"]}, {"Citation": "Ren J, Zhang A-H, Wang X-J. Traditional Chinese medicine for COVID-19 treatment. Pharmacol Res. (2020) 155:104743. 10.1016/j.phrs.2020.104743", "ArticleIdList": ["10.1016/j.phrs.2020.104743", "PMC7128263", "32145402"]}, {"Citation": "Shahzad A, Sharma S, Siddiqui SA. editors. Biotechnological Strategies for the Conservation of Medicinal and Ornamental Climbers. Cham: Springer International Publishing; (2016). 10.1007/978-3-319-19288-8", "ArticleIdList": ["10.1007/978-3-319-19288-8"]}, {"Citation": "Yang C-W, Lee Y-Z, Hsu H-Y, Shih C, Chao Y-S, Chang H-Y, et al. . Targeting coronaviral replication and cellular JAK2 mediated dominant NF-\u03baB activation for comprehensive and ultimate inhibition of coronaviral activity. Sci Rep. (2017) 7:4105. 10.1038/s41598-017-04203-9", "ArticleIdList": ["10.1038/s41598-017-04203-9", "PMC5481340", "28642467"]}, {"Citation": "Yang C-W, Lee Y-Z, Kang I-J, Barnard DL, Jan J-T, Lin D, et al. . Identification of phenanthroindolizines and phenanthroquinolizidines as novel potent anti-coronaviral agents for porcine enteropathogenic coronavirus transmissible gastroenteritis virus and human severe acute respiratory syndrome coronavirus. Antiv Res. (2010) 88:160\u20138. 10.1016/j.antiviral.2010.08.009", "ArticleIdList": ["10.1016/j.antiviral.2010.08.009", "PMC7114283", "20727913"]}, {"Citation": "Yang CW, Chang HY, Hsu HY, Lee YZ, Chang HS, Chen IS. Identification of anti-viral activity of the cardenolides, Na(+)/K(+)-ATPase inhibitors, against porcine transmissible gastroenteritis virus. Toxicol Appl Pharmacol. (2017) 332:129\u201337. 10.1016/j.taap.2017.04.017", "ArticleIdList": ["10.1016/j.taap.2017.04.017", "PMC7103123", "28438630"]}, {"Citation": "Yang C-W, Lee Y-Z, Hsu H-Y, Jan J-T, Lin Y-L, Chang S-Y, et al. . Inhibition of SARS-CoV-2 by highly potent broad-spectrum anti-coronaviral tylophorine-based derivatives. Front Pharmacol. (2020) 11:606097. 10.3389/fphar.2020.606097", "ArticleIdList": ["10.3389/fphar.2020.606097", "PMC7845692", "33519469"]}, {"Citation": "Islam MT, Sarkar C, El-Kersh DM, Jamaddar S, Uddin SJ, Shilpi JA, et al. . Natural products and their derivatives against coronavirus: a review of the non-clinical and pre-clinical data. Phytother Res. (2020) 34:2471\u201392. 10.1002/ptr.6700", "ArticleIdList": ["10.1002/ptr.6700", "32248575"]}, {"Citation": "Fielding BC, da Silva Maia Bezerra Filho C, Ismail NSM, de Sousa DP. Alkaloids: therapeutic potential against human coronaviruses. Molecules. (2020) 25:5496. 10.3390/molecules25235496", "ArticleIdList": ["10.3390/molecules25235496", "PMC7727683", "33255253"]}, {"Citation": "Schwarz S, Sauter D, Wang K, Zhang R, Sun B, Karioti A, et al. . Kaempferol derivatives as antiviral drugs against the 3a channel protein of coronavirus. Planta Med. (2014) 80:177\u201382. 10.1055/s-0033-1360277", "ArticleIdList": ["10.1055/s-0033-1360277", "PMC7171712", "24458263"]}, {"Citation": "Sharma V, Katiyar A, Agrawal RC. Glycyrrhiza glabra: chemistry and pharmacological activity. In: M\u00e9rillon JM, Ramawat KG, editors. Sweeteners: Pharmacology, Biotechnology, and Applications. Cham: Springer International Publishing; (2017). p. 87\u2013100. 10.1007/978-3-319-27027-2_21", "ArticleIdList": ["10.1007/978-3-319-27027-2_21"]}, {"Citation": "Khare CP. editor. Indian Medicinal Plants. New York, NY: Springer New York; (2007). 10.1007/978-0-387-70638-2", "ArticleIdList": ["10.1007/978-0-387-70638-2"]}, {"Citation": "Wang L, Yang R, Yuan B, Liu Y, Liu C. The antiviral and antimicrobial activities of licorice, a widely-used Chinese herb. Acta Pharmaceut Sin B. (2015) 5:310\u20135. 10.1016/j.apsb.2015.05.005", "ArticleIdList": ["10.1016/j.apsb.2015.05.005", "PMC4629407", "26579460"]}, {"Citation": "Cinatl J, Morgenstern B, Bauer G, Chandra P, Rabenau H, Doerr H. Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus. The Lancet. (2003) 361:2045\u20136. 10.1016/S0140-6736(03)13615-X", "ArticleIdList": ["10.1016/S0140-6736(03)13615-X", "PMC7112442", "12814717"]}, {"Citation": "Chang H-M, But PP-H, Yao S-C, Wang L-L, Yeung SC-S. Pharmacology and Applications of Chinese Materia Medica. Singapore: World Scientific; (1987). 10.1142/0377", "ArticleIdList": ["10.1142/0377"]}, {"Citation": "Ibrahim E, Mohamed A, Amin M, Emad-Eldin A, Dajem S, Bin SR, et al. . Antiviral activity of liquorice powder extract against varicella zoster virus isolated from Egyptian patients. Biomed J. (2012) 35:231. 10.4103/2319-4170.106149", "ArticleIdList": ["10.4103/2319-4170.106149", "22735054"]}, {"Citation": "Grienke U, Richter M, Braun H, Kirchmair J, Grafenstein S, von Liedl K, et al. . New insights into the anti-influenza activity of licorice constituents. Planta Med. (2013) 79:38. 10.1055/s-0033-1352073", "ArticleIdList": ["10.1055/s-0033-1352073"]}, {"Citation": "Ashraf A, Ashraf MM, Rafiqe A, Aslam B, Galani S, Zafar S, et al. . In vivo antiviral potential of Glycyrrhiza glabra extract against Newcastle disease virus. Pakistan J Pharmac Sci. (2017) 30:567\u201372.", "ArticleIdList": ["28650322"]}, {"Citation": "Clark K, Grant P, Sarr A, Belakere J, Swaggerty C, Phillips T, et al. . An in vitro study of theaflavins extracted from black tea to neutralize bovine rotavirus and bovine coronavirus infections. Vet Microbiol. (1998) 63:147\u201357. 10.1016/S0378-1135(98)00242-9", "ArticleIdList": ["10.1016/S0378-1135(98)00242-9", "PMC7117136", "9850995"]}, {"Citation": "Sharangi AB. Medicinal and therapeutic potentialities of tea (Camellia sinensis L.) \u2013 a review. Food Res Int. (2009) 42:529\u201335. 10.1016/j.foodres.2009.01.007", "ArticleIdList": ["10.1016/j.foodres.2009.01.007"]}, {"Citation": "Palit P, Chattopadhyay D, Thomas S, Kundu A, Kim HS, Rezaei N. Phytopharmaceuticals mediated Furin and TMPRSS2 receptor blocking: can it be a potential therapeutic option for Covid-19? Phytomedicine. (2021) 85:153396. 10.1016/j.phymed.2020.153396", "ArticleIdList": ["10.1016/j.phymed.2020.153396", "PMC7591300", "33380375"]}, {"Citation": "Sharma J, Kumar Bhardwaj V, Singh R, Rajendran V, Purohit R, Kumar S. An in-silico evaluation of different bioactive molecules of tea for their inhibition potency against non structural protein-15 of SARS-CoV-2. Food Chem. (2021) 346:128933. 10.1016/j.foodchem.2020.128933", "ArticleIdList": ["10.1016/j.foodchem.2020.128933", "PMC7831997", "33418408"]}, {"Citation": "Bhardwaj VK, Singh R, Sharma J, Rajendran V, Purohit R, Kumar S. Identification of bioactive molecules from tea plant as SARS-CoV-2 main protease inhibitors. J Biomol Struct Dyn. (2020). 10.1080/07391102.2020.1766572. [Epub ahead of print].", "ArticleIdList": ["10.1080/07391102.2020.1766572", "PMC7256349", "32397940"]}, {"Citation": "Sharma MP, Ahmad J, Hussain A, Khan S. Folklore medicinal plants of Mewat (Gurgaon District), Haryana, India. Int J Pharmac. (1992) 30:129\u201334. 10.3109/13880209209053975", "ArticleIdList": ["10.3109/13880209209053975"]}, {"Citation": "Singh B, Sharma RA. Secondary Metabolites of Medicinal Plants. Weinheim: Wiley-VCH Verlag GmbH & Co. KGaA (2020). 10.1002/9783527825578", "ArticleIdList": ["10.1002/9783527825578"]}, {"Citation": "Amber R, Adnan M, Tariq A, Mussarat S. A review on antiviral activity of the Himalayan medicinal plants traditionally used to treat bronchitis and related symptoms. J Pharm Pharmacol. (2017) 69:109\u201322. 10.1111/jphp.12669", "ArticleIdList": ["10.1111/jphp.12669", "PMC7166987", "27905101"]}, {"Citation": "Ahmed S, Gul S, Gul H, Bangash MH. Dual inhibitory activities of adhatoda vasica against cyclooxygenase and lipoxygenase. Int J Endors Health Sci Res. (2013) 1:14. 10.29052/IJEHSR.v1.i1.2013.14-17", "ArticleIdList": ["10.29052/IJEHSR.v1.i1.2013.14-17"]}, {"Citation": "Chavan R, Gohil D, Shah V, Kothari S, Chowdhary A. Antiviral activity of Indian medicinal plant Justicia adhatoda against herpes simplex virus: an in-vitro study. Int J Pharm Bio Sci. (2013) 4:769\u201378. Available online at: https://ijpbs.net/abstract.php?article=Mjc2NQ"}, {"Citation": "Pattanayak P, Behera P, Das D, Panda S. Ocimum sanctum Linn. A reservoir plant for therapeutic applications: An overview. Pharmacogn Rev. (2010) 4:95. 10.4103/0973-7847.65323", "ArticleIdList": ["10.4103/0973-7847.65323", "PMC3249909", "22228948"]}, {"Citation": "Ghoke SS, Sood R, Kumar N, Pateriya AK, Bhatia S, Mishra A, et al. . Evaluation of antiviral activity of Ocimum sanctum and Acacia arabica leaves extracts against H9N2 virus using embryonated chicken egg model. BMC Comple Alternat Med. (2018) 18:174. 10.1186/s12906-018-2238-1", "ArticleIdList": ["10.1186/s12906-018-2238-1", "PMC5987647", "29866088"]}, {"Citation": "Chiang L-C, Ng L-T, Cheng P-W, Chiang W, Lin C-C. Antiviral activities of extracts and selected pure constituents of Ocimum basilicum. Clin Exp Pharmacol Physiol. (2005) 32:811\u20136. 10.1111/j.1440-1681.2005.04270.x", "ArticleIdList": ["10.1111/j.1440-1681.2005.04270.x", "16173941"]}, {"Citation": "Cohen M. Tulsi-Ocimum sanctum: a herb for all reasons. J Ayurveda Integr Med. (2014) 5:251. 10.4103/0975-9476.146554", "ArticleIdList": ["10.4103/0975-9476.146554", "PMC4296439", "25624701"]}, {"Citation": "Shree P, Mishra P, Selvaraj C, Singh SK, Chaube R, Garg N, et al. . Targeting COVID-19 (SARS-CoV-2) main protease through active phytochemicals of ayurvedic medicinal plants Withania somnifera (Ashwagandha), Tinospora cordifolia (Giloy) and Ocimum sanctum (Tulsi) \u2013 a molecular docking study. J Biomol Struct Dyn. (2020) 1\u201314. 10.1080/07391102.2020.1810778", "ArticleIdList": ["10.1080/07391102.2020.1810778", "PMC7484581", "32851919"]}, {"Citation": "Penna SC, Medeiros MV, Aimbire FSC, Faria-Neto HCC, Serti\u00e9 JAA, Lopes-Martins RAB. Anti-inflammatory effect of the hydralcoholic extract of Zingiber officinale rhizomes on rat paw and skin edema. Phytomedicine. (2003) 10:381\u20135. 10.1078/0944-7113-00271", "ArticleIdList": ["10.1078/0944-7113-00271", "12834002"]}, {"Citation": "Karunakaran R, Sadanandan SP. Chapter 13 - zingiber officinale: antiinflammatory actions and potential usage for arthritic conditions. In: Watson RR, Preedy VR, editors. Bioactive Food as Dietary Interventions for Arthritis and Related Inflammatory Diseases. London: Academic Press; (2019). p. 233\u201344. 10.1016/B978-0-12-813820-5.00013-1", "ArticleIdList": ["10.1016/B978-0-12-813820-5.00013-1"]}, {"Citation": "Abd El-Wahab A, El-Adawi H, El-Demellawy M. In vitro study of the antiviral activity of Zingiber officinale. Planta Med. (2009) 75:F7. 10.1055/s-0029-1234649", "ArticleIdList": ["10.1055/s-0029-1234649"]}, {"Citation": "Chang JS, Wang KC, Yeh CF, Shieh DE, Chiang LC. Fresh ginger (Zingiber officinale) has anti-viral activity against human respiratory syncytial virus in human respiratory tract cell lines. J Ethnopharmacol. (2013) 145:146\u201351. 10.1016/j.jep.2012.10.043", "ArticleIdList": ["10.1016/j.jep.2012.10.043", "23123794"]}, {"Citation": "Kaushik S, Jangra G, Kundu V, Yadav JP, Kaushik S. Anti-viral activity of Zingiber officinale (Ginger) ingredients against the Chikungunya virus. Virus Dis. (2020) 31:270\u20136. 10.1007/s13337-020-00584-0", "ArticleIdList": ["10.1007/s13337-020-00584-0", "PMC7223110", "32420412"]}, {"Citation": "Koch C, Reichling J, Schneele J, Schnitzler P. Inhibitory effect of essential oils against herpes simplex virus type 2. Phytomedicine. (2008) 15:71\u20138. 10.1016/j.phymed.2007.09.003", "ArticleIdList": ["10.1016/j.phymed.2007.09.003", "17976968"]}, {"Citation": "Denyer CV, Jackson P, Loakes DM, Ellis MR, Young DAB. Isolation of antirhinoviral sesquiterpenes from Ginger (Zingiber officinale). J Natural Products. (1994) 57:658\u201362. 10.1021/np50107a017", "ArticleIdList": ["10.1021/np50107a017", "8064299"]}, {"Citation": "Tung BT, Nham DT, Hai NT, Thu DK. Chapter 10 - curcuma longa, the polyphenolic curcumin compound and pharmacological effects on liver. In: Watson RR, Preedy VR, editors. Bioactive Food as Dietary Interventions for Arthritis and Related Inflammatory Diseases. London: Academic Press; (2019). p. 125\u201334. 10.1016/B978-0-12-814466-4.00010-0", "ArticleIdList": ["10.1016/B978-0-12-814466-4.00010-0"]}, {"Citation": "Praditya D, Kirchhoff L, Br\u00fcning J, Rachmawati H, Steinmann J, Steinmann E. Anti-infective properties of the golden spice curcumin. Front Microbiol. (2019) 10:912. 10.3389/fmicb.2019.00912", "ArticleIdList": ["10.3389/fmicb.2019.00912", "PMC6509173", "31130924"]}, {"Citation": "Manoharan Y, Haridas V, Vasanthakumar KC, Muthu S, Thavoorullah FF, Shetty P. Curcumin: a wonder drug as a preventive measure for COVID19 management. Indian J Clin Biochem. (2020) 35:373\u20135. 10.1007/s12291-020-00902-9", "ArticleIdList": ["10.1007/s12291-020-00902-9", "PMC7299138", "32641876"]}, {"Citation": "Sornpet B, Potha T, Tragoolpua Y, Pringproa K. Antiviral activity of five Asian medicinal pant crude extracts against highly pathogenic H5N1 avian influenza virus. Asian Pacific J Trop Med. (2017) 10:871\u20136. 10.1016/j.apjtm.2017.08.010", "ArticleIdList": ["10.1016/j.apjtm.2017.08.010", "29080615"]}, {"Citation": "Dao TT, Nguyen PH, Won HK, Kim EH, Park J, Won BY, et al. . Curcuminoids from Curcuma longa and their inhibitory activities on influenza A neuraminidases. Food Chem. istry. (2012) 134:21\u20138. 10.1016/j.foodchem.2012.02.015", "ArticleIdList": ["10.1016/j.foodchem.2012.02.015"]}, {"Citation": "Shah B, Sheth F, Parabia M. Folk herbal knowledge on the management of respiratory disorders prevailing in ethnic society of Valsad district, Gujarat. Indian J Natural Products Resour. (2012) 3:438\u201347. Available online at: http://nopr.niscair.res.in/handle/123456789/14827"}, {"Citation": "El-Saber Batiha G, Alkazmi LM, Wasef LG, Beshbishy AM, Nadwa EH, Rashwan EK. Syzygium aromaticum L. (Myrtaceae): traditional uses, bioactive chemical constituents, pharmacological and toxicological activities. Biomolecules. (2020) 10:202. 10.3390/biom10020202", "ArticleIdList": ["10.3390/biom10020202", "PMC7072209", "32019140"]}, {"Citation": "Aboubakr HA, Nauertz A, Luong NT, Agrawal S, El-Sohaimy SAA, Youssef MM, et al. . In vitro antiviral activity of clove and ginger aqueous extracts against feline calicivirus, a surrogate for human norovirus. J Food Protect. (2016) 79:1001\u201312. 10.4315/0362-028X.JFP-15-593", "ArticleIdList": ["10.4315/0362-028X.JFP-15-593", "27296605"]}, {"Citation": "Mehmood Y, Farooq U, Yousaf H, Riaz H, Mahmood RK, Nawaz A, et al. . Antiviral activity of green silver nanoparticles produced using aqueous buds extract of Syzygium aromaticum. Pakistan J Pharmac Sci. (2020) 33:839\u201345. 10.36721/PJPS.2020.33.2.SUP.839-845.1", "ArticleIdList": ["10.36721/PJPS.2020.33.2.SUP.839-845.1", "32863260"]}, {"Citation": "Zeng X, Zhang P, Wang Y, Qin C, Chen S, He W, et al. . CMAUP: a database of collective molecular activities of useful plants. Nucleic Acids Res. (2019) 47:D1118\u201327. 10.1093/nar/gky965", "ArticleIdList": ["10.1093/nar/gky965", "PMC6324012", "30357356"]}, {"Citation": "Zeng X, Zhang P, He W, Qin C, Chen S, Tao L, et al. . NPASS: natural product activity and species source database for natural product research, discovery and tool development. Nucleic Acids Res. (2018) 46:D1217\u201322. 10.1093/nar/gkx1026", "ArticleIdList": ["10.1093/nar/gkx1026", "PMC5753227", "29106619"]}, {"Citation": "Shinbo Y, Nakamura Y, Altaf-Ul-Amin M, Asahi H, Kurokawa K, Arita M, et al. . KNApSAcK: a comprehensive species-metabolite relationship database. In: Plant Metabolomics. Berlin; Heidelberg: Springer-Verlag; (2006).p. 165\u201381. 10.1007/3-540-29782-0_13", "ArticleIdList": ["10.1007/3-540-29782-0_13"]}, {"Citation": "Berman HM. The protein data bank. Nucleic Acids Res. (2000) 28:235\u201342. 10.1093/nar/28.1.235", "ArticleIdList": ["10.1093/nar/28.1.235", "PMC102472", "10592235"]}, {"Citation": "Sarma P, Shekhar N, Prajapat M, Avti P, Kaur H, Kumar S, et al. . In-silico homology assisted identification of inhibitor of RNA binding against 2019-nCoV N-protein (N terminal domain). J Biomol Struct Dyn. (2020). 10.1080/07391102.2020.1753580. [Epub ahead of print].", "ArticleIdList": ["10.1080/07391102.2020.1753580", "PMC7256351", "32266867"]}, {"Citation": "Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS, et al. . AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comput Chem. (2009) 30:2785\u201391. 10.1002/jcc.21256", "ArticleIdList": ["10.1002/jcc.21256", "PMC2760638", "19399780"]}, {"Citation": "Samdani A, Vetrivel U. POAP: a GNU parallel based multithreaded pipeline of open babel and AutoDock suite for boosted high throughput virtual screening. Comput Biol Chem. (2018) 74:39\u201348. 10.1016/j.compbiolchem.2018.02.012", "ArticleIdList": ["10.1016/j.compbiolchem.2018.02.012", "29533817"]}, {"Citation": "O'Boyle NM, Banck M, James CA, Morley C, Vandermeersch T, Hutchison GR. Open Babel: an open chemical toolbox. J Cheminformat. (2011) 3:33. 10.1186/1758-2946-3-33", "ArticleIdList": ["10.1186/1758-2946-3-33", "PMC3198950", "21982300"]}, {"Citation": "Kriv\u00e1k R, Hoksza D. P2Rank: machine learning based tool for rapid and accurate prediction of ligand binding sites from protein structure. J Cheminformat. (2018) 10:39. 10.1186/s13321-018-0285-8", "ArticleIdList": ["10.1186/s13321-018-0285-8", "PMC6091426", "30109435"]}, {"Citation": "Salentin S, Schreiber S, Haupt VJ, Adasme MF, Schroeder M. PLIP: fully automated protein-ligand interaction profiler. Nucleic Acids Res. (2015) 43:W443\u20137. 10.1093/nar/gkv315", "ArticleIdList": ["10.1093/nar/gkv315", "PMC4489249", "25873628"]}, {"Citation": "Pires DEV, Blundell TL, Ascher DB. pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. J Med Chem. (2015) 58:4066\u201372. 10.1021/acs.jmedchem.5b00104", "ArticleIdList": ["10.1021/acs.jmedchem.5b00104", "PMC4434528", "25860834"]}, {"Citation": "DuBay KH, Hall ML, Hughes TF, Wu C, Reichman DR, Friesner RA. Accurate force field development for modeling conjugated polymers. J Chem Theor Comput. (2012) 8:4556\u201369. 10.1021/ct300175w", "ArticleIdList": ["10.1021/ct300175w", "26605615"]}, {"Citation": "Bernardes CES, Canongia Lopes JN, da Piedade MEM. All-atom force field for molecular dynamics simulations on organotransition metal solids and liquids. Application to M(CO) n (M = Cr, Fe, Ni, Mo, Ru, or W) compounds. J Phys Chem A. (2013) 117:11107\u201313. 10.1021/jp407739h", "ArticleIdList": ["10.1021/jp407739h", "24079472"]}, {"Citation": "Barth E, Kuczera K, Leimkuhler B, Skeel RD. Algorithms for constrained molecular dynamics. J Comput Chem. (1995) 16:1192\u2013209. 10.1002/jcc.540161003", "ArticleIdList": ["10.1002/jcc.540161003"]}, {"Citation": "Bulatov VV, Justo JF, Cai W, Yip S, Argon AS, Lenosky T, et al. . Parameter-free modelling of dislocation motion: the case of silicon. Philos Magaz A. (2001) 81:1257\u201381. 10.1080/01418610108214440", "ArticleIdList": ["10.1080/01418610108214440"]}, {"Citation": "Petersen HG. Accuracy and efficiency of the particle mesh Ewald method. J Chem Phys. (1995) 103:3668\u201379. 10.1063/1.470043", "ArticleIdList": ["10.1063/1.470043"]}, {"Citation": "Harvey MJ, De Fabritiis G. An implementation of the smooth particle Mesh Ewald method on GPU hardware. J Chem Theor Comput. (2009) 5:2371\u20137. 10.1021/ct900275y", "ArticleIdList": ["10.1021/ct900275y", "26616618"]}, {"Citation": "Berendsen HJC, Postma JPM, van Gunsteren WF, DiNola A, Haak JR. Molecular dynamics with coupling to an external bath. J Chem Phys. (1984) 81:3684\u201390. 10.1063/1.448118", "ArticleIdList": ["10.1063/1.448118", "0"]}, {"Citation": "Damm KL, Carlson HA. Gaussian-weighted RMSD superposition of proteins: a structural comparison for flexible proteins and predicted protein structures. Biophys J. (2006) 90:4558\u201373. 10.1529/biophysj.105.066654", "ArticleIdList": ["10.1529/biophysj.105.066654", "PMC1471868", "16565070"]}, {"Citation": "Kufareva I, Abagyan R. Methods of protein structure comparison. Methods Mol Biol. (2012) 857:231\u201357. 10.1007/978-1-61779-588-6_10", "ArticleIdList": ["10.1007/978-1-61779-588-6_10", "PMC4321859", "22323224"]}, {"Citation": "Fuglebakk E, Echave J, Reuter N. Measuring and comparing structural fluctuation patterns in large protein datasets. Bioinformatics. (2012) 28:2431\u201340. 10.1093/bioinformatics/bts445", "ArticleIdList": ["10.1093/bioinformatics/bts445", "22796957"]}, {"Citation": "Lobanov MY, Bogatyreva NS, Galzitskaya OV. Radius of gyration as an indicator of protein structure compactness. Mol Biol. (2008) 42:623\u20138. 10.1134/S0026893308040195", "ArticleIdList": ["10.1134/S0026893308040195", "18856071"]}, {"Citation": "Jim\u00e9nez J, \u0160kali\u010d M, Mart\u00ednez-Rosell G, De Fabritiis G. K DEEP: protein\u2013ligand absolute binding affinity prediction via 3D-convolutional neural networks. J Chem Inform Model. (2018) 58:287\u201396. 10.1021/acs.jcim.7b00650", "ArticleIdList": ["10.1021/acs.jcim.7b00650", "29309725"]}, {"Citation": "Poli G, Granchi C, Rizzolio F, Tuccinardi T. Application of MM-PBSA methods in virtual screening. Molecules. (2020) 25:1971. 10.3390/molecules25081971", "ArticleIdList": ["10.3390/molecules25081971", "PMC7221544", "32340232"]}, {"Citation": "Wang Z, Wang X, Li Y, Lei T, Wang E, Li D, et al. . farPPI: a webserver for accurate prediction of protein-ligand binding structures for small-molecule PPI inhibitors by MM/PB(GB)SA methods. Bioinformatics. (2019) 35:1777\u20139. 10.1093/bioinformatics/bty879", "ArticleIdList": ["10.1093/bioinformatics/bty879", "30329012"]}, {"Citation": "Jena AB, Kanungo N, Nayak V, Chainy GBN, Dandapat J. Catechin and curcumin interact with S protein of SARS-CoV2 and ACE2 of human cell membrane: insights from computational studies. Sci Rep. (2021) 11:2043. 10.1038/s41598-021-81462-7", "ArticleIdList": ["10.1038/s41598-021-81462-7", "PMC7820253", "33479401"]}, {"Citation": "Mohan RR, Wilson M, Gorham RD, Harrison RES, Morikis VA, Kieslich CA, et al. . Virtual screening of chemical compounds for discovery of complement C3 ligands. ACS Omega. (2018) 3:6427\u201338. 10.1021/acsomega.8b00606", "ArticleIdList": ["10.1021/acsomega.8b00606", "PMC6130793", "30221234"]}, {"Citation": "Li Q, Wu J, Nie J, Zhang L, Hao H, Liu S, et al. . The impact of mutations in SARS-CoV-2 spike on viral infectivity and antigenicity. Cell. (2020) 182:1284\u201394.e9. 10.1016/j.cell.2020.07.012", "ArticleIdList": ["10.1016/j.cell.2020.07.012", "PMC7366990", "32730807"]}, {"Citation": "Watanabe Y, Bowden TA, Wilson IA, Crispin M. Exploitation of glycosylation in enveloped virus pathobiology. Biochim Biophys Acta. (2019) 1863:1480\u201397. 10.1016/j.bbagen.2019.05.012", "ArticleIdList": ["10.1016/j.bbagen.2019.05.012", "PMC6686077", "31121217"]}, {"Citation": "Dalziel M, Crispin M, Scanlan CN, Zitzmann N, Dwek RA. Emerging principles for the therapeutic exploitation of glycosylation. Science. (2014) 343:1235681. 10.1126/science.1235681", "ArticleIdList": ["10.1126/science.1235681", "24385630"]}, {"Citation": "Watanabe Y, Berndsen ZT, Raghwani J, Seabright GE, Allen JD, Pybus OG, et al. . Vulnerabilities in coronavirus glycan shields despite extensive glycosylation. Nat Commun. (2020) 11:2688. 10.1038/s41467-020-16567-0", "ArticleIdList": ["10.1038/s41467-020-16567-0", "PMC7253482", "32461612"]}, {"Citation": "Yoshida T, Hatano T, Ito H, Okuda T. Chemical and biological perspectives of ellagitannin oligomers from medicinal plants. Stud Natural Products Chem. (2000) 23:395\u2013453. 10.1016/S1572-5995(00)80134-9", "ArticleIdList": ["10.1016/S1572-5995(00)80134-9"]}, {"Citation": "Chattopadhyay D. Ethnomedicinal antivirals: scope and opportunity. In: Ahmad I, Aqil F, Owais M, editors. Modern Phytomedicine. Weinheim: Wiley-VCH Verlag GmbH & Co. KGaA (2006). p. 313\u201339. 10.1002/9783527609987.ch15", "ArticleIdList": ["10.1002/9783527609987.ch15"]}, {"Citation": "Nonaka G-I, Harada M, Nishioka I. Eugeniin, a new ellagitannin from cloves. Chem Pharmac Bull. (1980) 28:685\u20137. 10.1248/cpb.28.685", "ArticleIdList": ["10.1248/cpb.28.685"]}, {"Citation": "Takechi M, Tanaka Y. Purification and characterization of antiviral substance from the bud of Syzygium aromatica. Planta Med. (1981) 42:69\u201374. 10.1055/s-2007-971548", "ArticleIdList": ["10.1055/s-2007-971548", "17401883"]}, {"Citation": "Kurokawa M, Hozumi T, Basnet P, Nakano M, Kadota S, Namba T, et al. . Purification and characterization of eugeniin as an anti-herpesvirus compound from Geum japonicum and Syzygium aromaticum. J Pharmacol Exp Therapeut. (1998) 284:728\u201335.", "ArticleIdList": ["9454821"]}, {"Citation": "Kurokawa M, Hozumi T, Tsurita M, Kadota S, Namba T, Shiraki K. Biological characterization of eugeniin as an anti-herpes simplex virus type 1 compound in vitro and in vivo. J Pharmacol Exp Therapeut. (2001) 297:372\u20139. Available online at: https://europepmc.org/article/med/11259565", "ArticleIdList": ["11259565"]}, {"Citation": "Saleem HN, Batool F, Mansoor HJ, Shahzad-ul-Hussan S, Saeed M. Inhibition of dengue virus protease by eugeniin, isobiflorin, and biflorin isolated from the flower buds of Syzygium aromaticum (Cloves). ACS Omega. (2019) 4:1525\u201333. 10.1021/acsomega.8b02861", "ArticleIdList": ["10.1021/acsomega.8b02861"]}, {"Citation": "Janyou A, Changtam C, Suksamrarn A, Tocharus C, Tocharus J. Suppression effects of O-demethyldemethoxycurcumin on thapsigargin triggered on endoplasmic reticulum stress in SK-N-SH cells. Neuro Toxicol. (2015) 50:92\u2013100. 10.1016/j.neuro.2015.08.005", "ArticleIdList": ["10.1016/j.neuro.2015.08.005", "26264395"]}, {"Citation": "Almanza A, Carlesso A, Chintha C, Creedican S, Doultsinos D, Leuzzi B, et al. . Endoplasmic reticulum stress signalling - from basic mechanisms to clinical applications. FEBS J. (2019) 286:241\u201378. 10.1111/febs.14608", "ArticleIdList": ["10.1111/febs.14608", "PMC7379631", "30027602"]}, {"Citation": "Aoe T. Pathological aspects of COVID-19 as a conformational disease and the use of pharmacological chaperones as a potential therapeutic strategy. Front Pharmacol. (2020) 11:1095. 10.3389/fphar.2020.01095", "ArticleIdList": ["10.3389/fphar.2020.01095", "PMC7366900", "32754041"]}, {"Citation": "Sureda A, Alizadeh J, Nabavi SF, Berindan-Neagoe I, Cismaru CA, Jeandet P, et al. . Endoplasmic reticulum as a potential therapeutic target for covid-19 infection management? Eur J Pharmacol. (2020) 882:173288. 10.1016/j.ejphar.2020.173288", "ArticleIdList": ["10.1016/j.ejphar.2020.173288", "PMC7297682", "32561291"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "2", "Day": "26"}, {"Year": "2021", "Month": "3", "Day": "31"}, {"Year": "2021", "Month": "5", "Day": "24", "Hour": "8", "Minute": "14"}, {"Year": "2021", "Month": "5", "Day": "25", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "5", "Day": "25", "Hour": "6", "Minute": "1"}, {"Year": "2021", "Month": "5", "Day": "7"}], "PublicationStatus": "epublish", "ArticleIdList": ["34026798", "PMC8137902", "10.3389/fmed.2021.672629"]}}], "PubmedBookArticle": []}